News – Page 334 – Endpoints News

Merck sued the US to block the drug pricing law. Will other pharma companies follow suit?

3 years ago

Senator Ron Wyden presses FDA and DEA on generic Adderall shortage

3 years ago

Samsung Biologics moves up plans to open its $1.5B+ plant

3 years ago

Young multiple sclerosis patients profess love — for family, travel, life and more — in new Novartis campaign

3 years ago

CBER's Peter Marks shares pandemic lessons as FDA continues 'going through the backlog'

3 years ago

Merck's CMV drug is approved for kidney transplant patients

3 years ago

Pharma marketers stand 'loudly and proudly' with LGBTQ+ community during Pride Month, despite boycotts in other ...

3 years ago

MarketingRx roundup: ASCO conference spotlights cancer campaign; Horizon, AZ lead Clio Health award wins

3 years ago

Italian AAV biotech closes $65M Series A; GSK's Jemperli nabs priority review in endometrial cancer

3 years ago

Novo Holdings, Gurnet Point Capital engineer $462M take-private deal for antibiotics player Paratek

3 years ago

Acepodia's off-the-shelf cell therapies get another $100M for oncology trials

3 years ago

Exclusive: GSK CEO Emma Walmsley talks about vaccines, M&A and the company’s future

3 years ago

Bain leads $150M round to push blindness biotech's rare disease drug toward FDA

3 years ago

Merck sues US government over IRA, challenging drug pricing bill’s constitutionality

3 years ago

Erasca touts early colorectal cancer data, trims a slate of trials and preclinical programs to refine focus

3 years ago

Idorsia notes potential $440.8M Asia licensing deal to extend cash runway amid slow Quviviq sales

3 years ago

Biopharma leaders paving the way for LGBTQ+ scientists, patients, entrepreneurs and C-suites

3 years ago

FDA to import versions of common cancer drug to alleviate shortage

3 years ago

After selling Rubraca, Clovis Oncology unveils CRL for potential label expansion

3 years ago

Daiichi Sankyo scores first nod for IV iron replacement drug in patients with heart failure

3 years ago

Amgen continues to target mid-December deadline for Horizon deal close

3 years ago

Early data show Bicara’s bispecific helps shrink head and neck cancers when combined with Keytruda: #ASCO23

3 years ago

Updated: FDA pulls paid Eisai consultant from temporary role on adcomm reviewing Eisai's new Alzheimer's drug

3 years ago

Biogen cuts PhIII Parkinson’s program over ‘long timeline’

3 years ago

First page Previous page 331 332 333334335 336 337 Next page Last page